PAHC vs QDEL: fair value comparison
Phibro Animal Health Corporation and QuidelOrtho Corporation · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, PAHC currently sits closer to the top of our discount ranking. PAHC carries the stronger quality grade. QDEL carries the stronger momentum grade.
| PAHC | QDEL | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $37.15 | $17.71 |
| 12-month range | $29.76–$54.68 | $12.64–$31.25 |
| Sector rank | #46 of 113 Healthcare | #50 of 113 Healthcare |
| Quality grade | D | F |
| Momentum grade | D | B |
| Leverage | High | Moderate |
| Margin trend | — | Expanding |
| Revenue growth | — | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| 52-week position | The lower-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: PAHC fair value analysis · QDEL fair value analysis